Oxford University Hospitals NHS Foundation Trust

Oxford, Oxfordshire OX3 9DU

3 studies enrolling now · 8 studies all time

What they study most

Atrial Fibrillation, Compensated Cirrhosis, Duchenne Muscular Dystrophy, Epithelial Tumor, Left Ventricular Fibrosis, Metastatic Cancer, Mitral Valve Prolapse, Nonalcoholic Steatohepatitis, Primary Biliary Cirrhosis, Stroke, Ischemic, Systemic Embolism, Ventricular Arrhythmias

Studies at this site

• The Fourth Left Atrial Appendage Occlusion Study — Recruiting now
• PRIMARY Ancillary Substudy — Recruiting now
• A Gene Transfer Therapy Study to Evaluate the Safety and Efficacy of Delandistrogene Moxeparvovec (SRP-9001) in Non-Ambulatory and Ambulatory Participants With Duchenne Muscular Dystrophy (DMD) — Running, not enrolling
• Talazoparib + Enzalutamide vs. Enzalutamide Monotherapy in mCRPC — Running, not enrolling
• A Long-term Follow-up Study of Participants Who Received Delandistrogene Moxeparvovec (SRP-9001) in a Previous Clinical Study — Enrolling by invitation
• Study of NG-641 in Combination With Nivolumab in Metastatic or Advanced Epithelial Tumours — Completed
• Study Evaluating the Efficacy and Safety of Obeticholic Acid in Subjects With Compensated Cirrhosis Due to Nonalcoholic Steatohepatitis — Completed
• Study to Assess Safety & Efficacy of GKT137831 in Patients With Primary Biliary Cholangitis Receiving Ursodiol. — Completed